Skip to content

Clinical trials

Triple Negative Breast Neoplasms trials in Ireland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Country / region: Ireland Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20161
20171
20182
20191
20201
20212
20221
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Active, not recruiting3
Completed3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
AstraZeneca1
Fondazione Michelangelo1
GBG Forschungs GmbH1
Gilead Sciences1
GlaxoSmithKline1
Hoffmann-La Roche1
Medicenna Therapeutics, Inc.1
Novartis Pharmaceuticals1
University College Cork1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms12
Breast Neoplasms2
Basal Cell Carcinoma1
Carcinoma, Ductal, Breast1
Carcinoma, Merkel Cell1
Carcinoma, Ovarian Epithelial1
Carcinoma, Renal Cell1
Colorectal Neoplasms1
Cutaneous Squamous Cell Carcinoma1
Endometrial Neoplasms1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.